Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 64, Issue 6, 2012, Pages 1740-1749

  Pierer, Matthias ^a   Rothe, Kathrin ^a   Quandt, Dagmar ^a   Schulz, Anett ^a   Rossol, Manuela ^a   Scholz, Roger ^a   Baerwald, Christoph ^a   Wagner, Ulf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOMEGALOVIRUS ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; JOINT DESTRUCTION; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS;

AGED; ANTIGENS, CD28; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84861820601     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34346     Document Type: Article

References (40)

1. null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165: 1138-45.
2. Wagner UG, Koetz K, Weyand CM, Goronzy JJ,. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998; 95: 14447-52.
3. null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol 2003; 33: 79-84.
4. Martens PB, Goronzy JJ, Schaid D, Weyand CM,. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997; 40: 1106-14.
5. + T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-85.
6. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB,. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 2008; 29: 650-9.
7. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114: 23-35.
8. +, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 1834-41.
9. Van Bergen J, Koning F,. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology 2010; 131: 301-9.
10. Thewissen M, Somers V, Venken K, Linsen L, van Paassen P, Geusens P, et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 2007; 123: 209-18.
11. - T cells in rheumatoid arthritis. J Rheumatol 1999; 26: 1452-7.
12. Steinbrocker O, Traeger CH, Batterman RC,. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
13. Bottcher J, Pfeil A, Mentzel H, Kramer A, Schafer ML, Lehmann G, et al. Peripheral bone status in rheumatoid arthritis evaluated by digital X-ray radiogrammetry and compared with multisite quantitative ultrasound. Calcif Tissue Int 2006; 78: 25-34.
14. + T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNFα. J Immunol 2004; 173: 2825-33.
15. Wagner U, Kaltenhauser S, Pierer M, Seidel W, Troltzsch M, Hantzschel H, et al. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 553-62.
16. null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007; 179: 6514-23.
17. + T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175: 8218-25.
18. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 2009; 5: e1000427.
19. + T cells. J Immunol 2004; 173: 7223-9.
20. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744-8.
21. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum 2004; 50: 43-54.
22. Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, et al. The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R210-3.
23. Schmidt D, Goronzy JJ, Weyand CM,. CD4+CD7-CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97: 2027-37.
24. + T cells specific for cytomegalovirus. J Immunol 2009; 182: 4175-82.
25. Lamprecht P, Moosig F, Csernok E, Seitzer U, Schnabel A, Mueller A, et al. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001; 56: 751-7.
26. null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50: 1450-8.
27. Dutra WO, Martins-Filho OA, Cancado JR, Pinto-Dias JC, Brener Z, Gazzinelli G, et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 1996; 43: 88-93.
28. Bryl E, Vallejo AN, Weyand CM, Goronzy JJ,. Down-regulation of CD28 expression by TNF-α. J Immunol 2001; 167: 3231-8.
29. - T cell subsets. Bone Marrow Transplant 2001; 27: 1095-100.
30. Porakishvili N, Roschupkina T, Kalber T, Jewell AP, Patterson K, Yong K, et al. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol 2001; 126: 29-36.
31. Walton JA, Lydyard PM, Nathwani A, Emery V, Akbar A, Glennie MJ, et al. Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype. Br J Haematol 2010; 148: 274-84.
32. Goronzy JJ, Weyand CM,. Rheumatoid arthritis. Immunol Rev 2005; 204: 55-73.
33. pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments. Arthritis Res Ther 2010; 12: R142.
34. + T-cell repertoire. J Virol 2007; 81: 7759-65.
35. + T cells during primary cytomegalovirus infection. J Clin Invest 2000; 105: 541-8.
36. + T cell IFNγ expression and proliferation responses in healthy CMV-seropositive individuals. Viral Immunol 2004; 17: 445-54.
37. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM,. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000; 97: 9203-8.
38. + T-cell repertoire. Blood 2010; 116: 2968-74.
39. Akbar AN,. The silent war against CMV in CLL. Blood 2010; 116: 2869-70.
40. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM,. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998; 41: 2108-16.